Ray Takigiku

Ray Takigiku, PhD is the founder of Bexion Pharmaceuticals, an oncology-focused company with a novel compound in clinical development for solid tumors. In addition, he serves as Chief Scientific Officer leading all scientific, clinical, research and development efforts, and advising company strategy. Ray is an entrepreneurial life scientist with over 30 years of experience in the discovery, development, and market support of innovative pharmaceuticals. At P&G Pharmaceuticals, Ray was on the leadership team behind the blockbuster Actonel. After leaving P&G, Ray joined SIDIS Global, an investment and management firm creating next-generation laboratory instrumentation, medical devices, and healthcare related services.